Exchange: NASDAQ·Updated 06:41 PM EDT

TEM News

News
all
press releases
Tempus AI Chief Accounting Officer Sells $529,650 of Stock
Key PointsThe transaction involved 7,062 shares with an estimated value of $529,650 as of the transaction date...
Nasdaq News: Markets
Tempus AI Chief Accounting Officer Sells $529,650 of Stock
Key PointsThe transaction involved 7,062 shares with an estimated value of $529,650 as of the transaction date...
Nasdaq News: Markets
More News
Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4
AI adoption is reshaping medical devices, with ISRG, TEM and TMO leveraging AI to advance precision medicine and drug development.
Zacks
Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursions RNA Foundation Model
Tempus AI, Inc. (NASDAQ: TEM) today announced an extension of its data license agreement with Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX). Additionally, the two companies have entered into a new agreement under which Tempus will license Recursions RNA Foundation Model. Tempus and Recursion have...
Business Wire
Strength Seen in Tempus (TEM): Can Its 14.9% Jump Turn into More Strength?
Tempus (TEM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
Zacks Investment Ideas feature highlights: NVIDIA, Advanced Micro Devices, Tempus, Moderna, Super Micro Computer and Aya Gold & Silver
NVIDIA, Advanced Micro Devices, Tempus, Moderna, Super Micro Computer and Aya Gold & Silver have been highlighted in this Investment Ideas article.
Zacks
Will 2026 Doom and Gloom Lead to Opportunity?
While macroeconomic headwinds, geopolitical energy shocks, and relentless media fear-mongering might suggest a market correction is overdue, the resilience of stock price action tells a different story.
Zacks
Neuraxis Gains Nearly 137% in a Year: What's Driving the Stock?
NRXS is benefiting from stronger IB-Stim volumes, broader reimbursement and VA access, but incomplete payer coverage and cash needs remain challenges.
Zacks
Tempus AI CEO Eric Lefkofsky: Healthcare will likely be the biggest beneficiary of AI
Tempus AI CEO Eric Lefkofsky: Healthcare will likely be the biggest beneficiary of AI...
CNBC Television-YouTube
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033 AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033PR NewswireAUSTIN, Texas, Sept. 14, 2026 AUSTIN, Texas, Sept. 14, 2026 /PRNewswire/ -- USA News Group News Commentary- Artificial intelligence is moving from the edges...
PR Newswire
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation
Tempus AI, Inc. (NASDAQ: TEM) today announced an initiative to build a research platform containing 100,000 whole genomes linked to longitudinal clinical information over the next several years. The effort will create the first de-identified multimodal whole-genome sequencing (WGS) dataset built...
Business Wire

Advertisement|Remove ads.